Horizon Therapeutics USA, Inc
Registered Principal Details
Business Or Interest:
Pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases.
Lobbying Interests:
All matters relating to the pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases
CEO Name:
Tim Walbert
Director
Pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases.
Lobbying Interests:
All matters relating to the pharmaceutical industry and medicines for rare, autoimmune and severe inflammatory diseases
CEO Name:
Tim Walbert
Director
Contact
JI
Julie Idelkope
1 Horizon Way
Deerfield, IL 60015
(612) 805-5493
jidelkope@horizontherapeutics.com
https://www.horizontherapeutics.com/
1 Horizon Way
Deerfield, IL 60015
(612) 805-5493
jidelkope@horizontherapeutics.com
https://www.horizontherapeutics.com/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 744
Relating to: rare disease advisory council. (FE)
Bill Text and History
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Relating to: rare disease advisory council. (FE)
Bill Text and History
1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: rare disease advisory council. (FE)
Bill Text and History
For
Notification Date1/4/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
10/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2021 July - December |
2022 January - June |
2022 July - December |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2021 July - December $15,000.00 |
2022 January - June $18,000.00 |
2022 July - December $18,000.00 |
Total $51,000.00 |
| Total Hours Communicating | 2021 July - December 0.00 |
2022 January - June 3.00 |
2022 July - December 0.00 |
Total 3.00 |
| Total Hours Other | 2021 July - December 3.00 |
2022 January - June 11.50 |
2022 July - December 0.00 |
Total 14.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 20% |
2022 July - December |
Total 17% |
Relating to: rare disease advisory council. (FE)
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December |
2022 January - June 70% |
2022 July - December |
Total 57% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the creation of a Rare Disease Advisory Council.
| 2021 January - June |
2021 July - December |
2022 January - June |
2022 July - December |
Total |
|---|---|---|---|---|
| 2021 January - June |
2021 July - December 100% |
2022 January - June 10% |
2022 July - December |
Total 25% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.